Androgen receptor mutations in prostate cancer.

Abstract excerpt

AR gene mutations occur in both early-stage prostate cancers (28, 51, our unpublished data) and late-stage disease (36, 37, 55-57). One common feature is that both types of mutations retain ligand-dependent transcriptional activity. We speculate that AR mutations may characterize a more aggressive disease, or confer an ability to survive androgen ablation therapy. A large percentage of tumors appears to have no...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Gene Expression Regulation, Neoplastic
• Share to Mutation
• Share to Polymorphism, Genetic